Literature DB >> 3513750

The mechanism of fibrin-induced disorganization of cultured human endothelial cell monolayers.

B Weimar, U Delvos.   

Abstract

Deposition of polymerizing fibrin on the vascular endothelium is the final event in intravascular coagulation. Exposure of fibrin clots to confluent monolayers of cultured human endothelial cells for 4 to 24 hours resulted in the disappearance of their normal cobblestone morphology and in the formation of endothelial cell aggregates. The present study was designed to evaluate the conditions and structural requirements of the fibrin clot for the induction of disorganization. Even after harsh treatment with denaturing agents or loading with large amounts of fibrinogen antibodies, polymerized fibrin always induced disorganization of the monolayers. In contrast, soluble fibrin that was kept in solution by either fibrinogen, fragment D-cate, or the tetrapeptide Gly-Pro-Arg-Pro did not cause any alteration of the monolayers. The fibrinogen degradation product D-cate (Mr 94,000) itself had no microscopically detectable influence on the monolayer structure. In the absence of fibrin, the effect of thrombin on endothelial cells was found to be distinct from that induced by fibrin; however, the exposure of pieces of glass coverslips caused alterations in morphology indistinguishable from the fibrin-induced disorganization of the monolayer. Experiments using protein-coated polyester films indicated that the ability of the endothelial cells to attach to the overlying material, independent of its chemical structure, is the prerequisite for the induction of disorganization, but not a defined component of the fibrin molecule. Disorganization of vascular endothelium in vivo might be important for the organization and revascularization of an occluding thrombus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3513750     DOI: 10.1161/01.atv.6.2.139

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  9 in total

1.  Endothelial cell spreading on fibrin requires fibrinopeptide B cleavage and amino acid residues 15-42 of the beta chain.

Authors:  L A Bunce; L A Sporn; C W Francis
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

2.  Lack of effect of thrombin on fibrin(ogen)-endothelial cell interaction.

Authors:  E Réganon; V Vila; V Martínez-Sales; J Aznar
Journal:  Cytotechnology       Date:  1995-06       Impact factor: 2.058

3.  Mediation of fibrin-induced release of von Willebrand factor from cultured endothelial cells by the fibrin beta chain.

Authors:  J A Ribes; F Ni; D D Wagner; C W Francis
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

4.  Susceptibility of irradiated bovine aortic endothelial cells to injury.

Authors:  M H Zhou; Q Dong; C Ts'ao
Journal:  Am J Pathol       Date:  1988-11       Impact factor: 4.307

5.  Effect of lipopolysaccharides on cultured human endothelial cells. Relationship between tissue factor activity and prostacyclin release.

Authors:  U Delvos; B Janssen; G Müller-Berghaus
Journal:  Blut       Date:  1987-08

Review 6.  Thrombosis and atherosclerosis: regulatory role of interactions among blood components and endothelium.

Authors:  R E Scharf; L A Harker
Journal:  Blut       Date:  1987-09

7.  The platelet glycoprotein IIb/IIIa-like protein in human endothelial cells promotes adhesion but not initial attachment to extracellular matrix.

Authors:  C S Chen; P Thiagarajan; S M Schwartz; J M Harlan; R L Heimark
Journal:  J Cell Biol       Date:  1987-10       Impact factor: 10.539

8.  Plasma fibrinolysis is related to the degree of organ dysfunction but not to the concentration of von Willebrand Factor in critically ill patients.

Authors:  Karim Zouaoui Boudjeltia; Sandra Ollieuz; Michael Piagnerelli; Patrick Biston; Philippe Cauchie; Jean-Louis Vincent; Dany Brohee; Michel Vanhaeverbeek
Journal:  Thromb J       Date:  2009-06-19

9.  The selective binding and transmigration of monocytes through the junctional complexes of human endothelium.

Authors:  N A Pawlowski; G Kaplan; E Abraham; Z A Cohn
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.